Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for HDL in Type 2 Diabetes (SILHOUETTE)
NCT00389896Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2001
- Primary completion
- Oct 2002
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of simvastatin in diabetic dyslipidemia and low hdl cholesterol (6 arms), sponsored by Organon & Co. Primary endpoint: High-Density Lipoprotein Cholesterol at 6 weeks. Started Jul 2001; status: completed.
02
Drugs
simvastatin
03
Conditions
diabetic dyslipidemialow hdl cholesterol
Beyond the preview
Go deeper on NCT00389896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389896.